Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A comprehensive study of calcific aortic stenosis: from rabbit to human samples.

Mourino-Alvarez L, Baldan-Martin M, Sastre-Oliva T, Martin-Lorenzo M, Maroto AS, Corbacho-Alonso N, Rincon R, Martin-Rojas T, Lopez-Almodovar LF, Alvarez-Llamas G, Vivanco F, Padial LR, de la Cuesta F, Barderas MG.

Dis Model Mech. 2018 Jun 19;11(6). pii: dmm033423. doi: 10.1242/dmm.033423.

2.

Decision Making of Graduation in Patients With Early-Onset Scoliosis at the End of Distraction-Based Programs: Risks and Benefits of Definitive Fusion.

Pizones J, Martín-Buitrago MP, Sánchez Márquez JM, Fernández-Baíllo N, Baldan-Martin M, Sánchez Pérez-Grueso FJ.

Spine Deform. 2018 May - Jun;6(3):308-313. doi: 10.1016/j.jspd.2017.10.005.

PMID:
29735142
3.

Translational science in albuminuria: a new view of de novo albuminuria under chronic RAS suppression.

Baldan-Martin M, Rodríguez-Sánchez E, González-Calero L, Ruilope LM, Alvarez-Llamas G, Barderas MG, Ruiz-Hurtado G.

Clin Sci (Lond). 2018 Apr 6;132(7):739-758. doi: 10.1042/CS20180097. Print 2018 Apr 16. Review.

PMID:
29626149
4.

Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.

Baldan-Martin M, Lopez JA, Corbacho-Alonso N, Martinez PJ, Rodriguez-Sanchez E, Mourino-Alvarez L, Sastre-Oliva T, Martin-Rojas T, Rincón R, Calvo E, Vazquez J, Vivanco F, Padial LR, Alvarez-Llamas G, Ruiz-Hurtado G, Ruilope LM, Barderas MG.

Sci Rep. 2018 Mar 19;8(1):4802. doi: 10.1038/s41598-018-23037-7.

5.

Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Martin-Lorenzo M, Gonzalez-Calero L, Martinez PJ, Baldan-Martin M, Lopez JA, Ruiz-Hurtado G, de la Cuesta F, Segura J, Vazquez J, Vivanco F, Barderas MG, Ruilope LM, Alvarez-Llamas G.

Sci Rep. 2018 Mar 2;8(1):4154. doi: 10.1038/s41598-018-22185-0.

6.

Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response.

Martin-Lorenzo M, Martinez PJ, Baldan-Martin M, Ruiz-Hurtado G, Prado JC, Segura J, de la Cuesta F, Barderas MG, Vivanco F, Ruilope LM, Alvarez-Llamas G.

Hypertension. 2017 Nov;70(5):1049-1056. doi: 10.1161/HYPERTENSIONAHA.117.09819. Epub 2017 Sep 5.

PMID:
28874460
7.

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Martin-Lorenzo M, Gonzalez-Calero L, Martinez PJ, Baldan-Martin M, Lopez JA, Ruiz-Hurtado G, de la Cuesta F, Segura J, Vazquez J, Vivanco F, Barderas MG, Ruilope LM, Alvarez-Llamas G.

Sci Rep. 2017 Aug 21;7(1):8894. doi: 10.1038/s41598-017-09042-2. Erratum in: Sci Rep. 2018 Mar 2;8(1):4154.

8.

Recent advances and clinical insights into the use of proteomics in the study of atherosclerosis.

Mourino-Alvarez L, Baldan-Martin M, Rincon R, Martin-Rojas T, Corbacho-Alonso N, Sastre-Oliva T, Barderas MG.

Expert Rev Proteomics. 2017 Aug;14(8):701-713. doi: 10.1080/14789450.2017.1353912. Epub 2017 Jul 14. Review.

PMID:
28689450
9.

Proteomic Analysis of Blood Extracellular Vesicles in Cardiovascular Disease by LC-MS/MS Analysis.

Baldan-Martin M, de la Cuesta F, Alvarez-Llamas G, Ruiz-Hurtado G, Ruilope LM, Barderas MG.

Methods Mol Biol. 2017;1619:141-149. doi: 10.1007/978-1-4939-7057-5_11.

PMID:
28674883
10.

Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.

Gonzalez-Calero L, Martínez PJ, Martin-Lorenzo M, Baldan-Martin M, Ruiz-Hurtado G, de la Cuesta F, Calvo E, Segura J, Lopez JA, Vázquez J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Oncotarget. 2017 Jul 4;8(27):44217-44231. doi: 10.18632/oncotarget.17787.

11.

Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria.

de la Cuesta F, Baldan-Martin M, Moreno-Luna R, Alvarez-Llamas G, Gonzalez-Calero L, Mourino-Alvarez L, Sastre-Oliva T, López JA, Vázquez J, Ruiz-Hurtado G, Segura J, Vivanco F, Ruilope LM, Barderas MG.

Oncotarget. 2017 Feb 28;8(9):15553-15562. doi: 10.18632/oncotarget.14948.

12.

Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport.

Mourino-Alvarez L, Baldan-Martin M, Gonzalez-Calero L, Martinez-Laborde C, Sastre-Oliva T, Moreno-Luna R, Lopez-Almodovar LF, Sanchez PL, Fernandez-Aviles F, Vivanco F, Padial LR, Akerstrom F, Alvarez-Llamas G, de la Cuesta F, Barderas MG.

Int J Cardiol. 2016 Dec 15;225:99-106. doi: 10.1016/j.ijcard.2016.09.089. Epub 2016 Sep 26.

PMID:
27716559
13.

Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression.

Gonzalez-Calero L, Martin-Lorenzo M, Martínez PJ, Baldan-Martin M, Ruiz-Hurtado G, Segura J, de la Cuesta F, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Transl Res. 2016 Dec;178:25-37.e7. doi: 10.1016/j.trsl.2016.07.003. Epub 2016 Jul 15.

PMID:
27477079
14.

Plasma Molecular Signatures in Hypertensive Patients With Renin-Angiotensin System Suppression: New Predictors of Renal Damage and De Novo Albuminuria Indicators.

Baldan-Martin M, Mourino-Alvarez L, Gonzalez-Calero L, Moreno-Luna R, Sastre-Oliva T, Ruiz-Hurtado G, Segura J, Lopez JA, Vazquez J, Vivanco F, Alvarez-Llamas G, Ruilope LM, de la Cuesta F, Barderas MG.

Hypertension. 2016 Jul;68(1):157-66. doi: 10.1161/HYPERTENSIONAHA.116.07412. Epub 2016 May 23.

PMID:
27217411
15.

[Cardiovascular risk study in patients with renin-angiotensin system blockade by means of the proteone of circulating extracellular vesicles].

de la Cuesta F, Baldan-Martin M, Mourino-Alvarez L, Sastre-Oliva T, Alvarez-Llamas G, Gonzalez-Calero L, Ruiz-Hurtado G, Segura J, Vivanco F, Ruilope LM, Barderas MG.

Hipertens Riesgo Vasc. 2016 Jan-Mar;33(1):21-7. doi: 10.1016/j.hipert.2015.07.003. Epub 2015 Sep 19. Spanish.

PMID:
26826536
16.

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.

Gonzalez-Calero L, Martin-Lorenzo M, de la Cuesta F, Maroto AS, Baldan-Martin M, Ruiz-Hurtado G, Pulido-Olmo H, Segura J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Cardiovasc Diabetol. 2016 Jan 16;15:8. doi: 10.1186/s12933-016-0331-7.

17.

Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics.

Baldan-Martin M, de la Cuesta F, Alvarez-Llamas G, Gonzalez-Calero L, Ruiz-Hurtado G, Moreno-Luna R, Mourino-Alvarez L, Sastre-Oliva T, Segura J, Padial LR, Vivanco F, Ruilope LM, Barderas MG.

Int J Cardiol. 2015 Oct 1;196:170-7. doi: 10.1016/j.ijcard.2015.05.148. Epub 2015 May 29.

PMID:
26119064

Supplemental Content

Loading ...
Support Center